Diagnostic criteria of perfluorobutane-enhanced ultrasonography for diagnosing hepatocellular carcinoma in high-risk individuals: how is late washout determined?
Ultrasonography. 2022;41(3):530-542 
Perfluorobutane-enhanced ultrasonography with a Kupffer phase: improved diagnostic sensitivity for hepatocellular carcinoma
European Radiology. 2022;32(12):8507-8517
The Kupffer phase of Sonazoid-enhanced ultrasound as the major imaging feature for diagnosing hepatocellular carcinoma in at-risk individuals
Journal of Hepatology. 2023;78:S509
Non‐invasive diagnostic criteria for hepatocellular carcinoma: The value of contrast washout at imaging and the death of alpha‐fetoprotein
Liver International. 2011;31(10):1419-1421
Diagnostic Accuracy of Contrast-enhanced Ultrasonography Liver Imaging Reporting and Data System in Hepatocellular Carcinoma: A Systematic Review
. 2021;
Local ablation therapy with contrast-enhanced ultrasonography for hepatocellular carcinoma: a practical review
Ultrasonography. 2015;34(4):235-245
Contrast-enhanced ultrasound of hepatocellular carcinoma: where do we stand?
Ultrasonography. 2019;38(3):200-214
Contrast-enhanced ultrasound imaging features and clinical characteristics of combined hepatocellular cholangiocarcinoma: comparison with hepatocellular carcinoma and cholangiocarcinoma
Ultrasonography. 2020;39(4):356-366
How reader perception of capsule affects interpretation of washout in hypervascular liver nodules in patients at risk for hepatocellular carcinoma
Journal of Magnetic Resonance Imaging. 2015;43(6):1337-1345
Gadoxetic Acid–enhanced Magnetic Resonance Imaging and Contrast-enhanced Ultrasonography in the Diagnosis of Hepatocellular Carcinoma
Hong Kong Journal of Radiology. 2017;